Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 93

1.

Delayed response to proton beam treatment of hepatocellular carcinoma.

Cheng CW, Machtay M, Dorth J, Sergeeva O, Xia H, Manaspon C, Wu H, Iyer R, Sexton S, Xin W, Exner AA, Lee Z.

BJR Case Rep. 2020 Feb 12;6(1):20180125. doi: 10.1259/bjrcr.20180125. eCollection 2020 Mar.

2.

A Translational Hepatic Artery Infusion (HAI) Model for Hepatocellular Carcinoma in Woodchucks.

Kim M, Powers CA, Curtin LI, Fisher DT, Sexton S, Gurova KV, Skitzki JJ, Iyer RV.

J Surg Res. 2020 Mar 3;251:126-136. doi: 10.1016/j.jss.2020.02.002. [Epub ahead of print]

PMID:
32143057
3.

A multicentre phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma.

Fountzilas C, Gupta M, Lee S, Krishnamurthi S, Estfan B, Wang K, Attwood K, Wilton J, Bies R, Bshara W, Iyer R.

Br J Cancer. 2020 Feb 10. doi: 10.1038/s41416-020-0737-6. [Epub ahead of print]

PMID:
32037403
4.

Poly(ADP-Ribose) Polymerase Inhibitors in Pancreatic Cancer: A New Treatment Paradigms and Future Implications.

Gupta M, Iyer R, Fountzilas C.

Cancers (Basel). 2019 Dec 9;11(12). pii: E1980. doi: 10.3390/cancers11121980. Review.

5.

Role of Adjuvant Chemotherapy in Pulmonary Carcinoids: An NCDB Analysis.

Gosain R, Groman A, Yendamuri SS, Iyer R, Mukherjee S.

Anticancer Res. 2019 Dec;39(12):6835-6842. doi: 10.21873/anticanres.13900.

PMID:
31810950
6.

Phase I Study of Irinotecan/5-Fluorouracil/Leucovorin (FOLFIRI) with Sunitinib for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

Mukherjee S, Fountzilas C, Boland PM, Gosain R, Attwood K, Tan W, Khushalani N, Iyer R.

Target Oncol. 2020 Feb;15(1):85-92. doi: 10.1007/s11523-019-00692-y.

PMID:
31802410
7.

[18F] Clofarabine for PET Imaging of Hepatocellular Carcinoma.

Sergeeva O, Kepe V, Zhang Y, Miller-Atkins GA, Keynon JD, Iyer R, Sexton S, Awadallah A, Xin W, Saunthararajah Y, Chan ER, Lee Z.

Cancers (Basel). 2019 Nov 7;11(11). pii: E1748. doi: 10.3390/cancers11111748.

8.

Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates.

Malhotra U, Mukherjee S, Fountzilas C, Boland P, Miller A, Patnaik S, Attwood K, Yendamuri S, Adjei A, Kannisto E, Opyrchal M, Bushunow P, Loud P, Iyer R, Khushalani N.

Mol Cancer Ther. 2020 Jan;19(1):304-311. doi: 10.1158/1535-7163.MCT-19-0240. Epub 2019 Oct 1.

PMID:
31575653
9.

Augmentation of IFN-γ+ CD8+ T cell responses correlates with survival of HCC patients on sorafenib therapy.

Kalathil SG, Hutson A, Barbi J, Iyer R, Thanavala Y.

JCI Insight. 2019 Aug 8;4(15). pii: 130116. doi: 10.1172/jci.insight.130116. eCollection 2019 Aug 8.

10.

Multidisciplinary Management of Patients with Unresectable Hepatocellular Carcinoma: A Critical Appraisal of Current Evidence.

Gholam PM, Iyer R, Johnson MS.

Cancers (Basel). 2019 Jun 22;11(6). pii: E873. doi: 10.3390/cancers11060873. Review.

11.

Interleukin-6 as a biomarker in patients with hepatobiliary cancers.

Gosain R, Anwar S, Miller A, Iyer R, Mukherjee S.

J Gastrointest Oncol. 2019 Jun;10(3):537-545. doi: 10.21037/jgo.2019.01.09.

12.

PET imaging of hepatocellular carcinoma with anti-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in comparison with L-[S-methyl-11C]methionine.

Sergeeva O, Zhang Y, Kenyon JD, Miller-Atkins GA, Wu C, Iyer R, Sexton S, Wojtylak P, Awadallah A, Xin W, Chan ER, O'Donnel JK, Lee Z.

EJNMMI Res. 2019 May 22;9(1):47. doi: 10.1186/s13550-019-0519-4.

13.

Dose-Dependent Sorafenib-Induced Immunosuppression Is Associated with Aberrant NFAT Activation and Expression of PD-1 in T Cells.

Iyer RV, Maguire O, Kim M, Curtin LI, Sexton S, Fisher DT, Schihl SA, Fetterly G, Menne S, Minderman H.

Cancers (Basel). 2019 May 16;11(5). pii: E681. doi: 10.3390/cancers11050681.

14.

Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.

Benson AB, D'Angelica MI, Abbott DE, Abrams TA, Alberts SR, Anaya DA, Anders R, Are C, Brown D, Chang DT, Cloyd J, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley RK, Kim R, Palta M, Park JO, Sahai V, Schefter T, Sicklick JK, Singh G, Sohal D, Stein S, Tian GG, Vauthey JN, Venook AP, Hammond LJ, Darlow SD.

J Natl Compr Canc Netw. 2019 Apr 1;17(4):302-310. doi: 10.6004/jnccn.2019.0019.

PMID:
30959462
15.

Management of Typical and Atypical Pulmonary Carcinoids Based on Different Established Guidelines.

Gosain R, Mukherjee S, Yendamuri SS, Iyer R.

Cancers (Basel). 2018 Dec 12;10(12). pii: E510. doi: 10.3390/cancers10120510. Review.

16.

Woodchuck VEGF (wVEGF) characteristics: Model for angiogenesis and human hepatocellular carcinoma directed therapies.

Huang H, Salavaggione O, Rivera L, Mukherjee S, Brekken R, Tennant B, Iyer R, Adjei A.

Arch Biochem Biophys. 2019 Jan;661:97-106. doi: 10.1016/j.abb.2018.11.008. Epub 2018 Nov 13.

PMID:
30439360
17.

A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients.

Ma WW, Xie H, Fetterly G, Pitzonka L, Whitworth A, LeVea C, Wilton J, Mantione K, Schihl S, Dy GK, Boland P, Iyer R, Tan W, Brady W, Straubinger RM, Adjei AA.

Am J Clin Oncol. 2019 Feb;42(2):184-189. doi: 10.1097/COC.0000000000000492.

18.

A phase 1, open-label, dose escalation study of intravenous paricalcitol in combination with gemcitabine in patients with advanced malignancies.

Fountzilas C, Javle M, Tan W, Ma Y, Fetterly G, Iyer R, Johnson C.

Cancer. 2018 Oct 1;124(19):3890-3899. doi: 10.1002/cncr.31676. Epub 2018 Oct 9.

19.

Cholangiocarcinoma: Treatment, Outcomes, and Nutrition Overview for Oncology Nurses.

Acquisto S, Iyer R, Rosati LM, Pinheirn N, Driskill K, Musto K, Lowitzer H, Bradley E, Drapek L.

Clin J Oncol Nurs. 2018 Aug 1;22(4):E97-E102. doi: 10.1188/18.CJON.E97-E102. Review.

PMID:
30035775
20.

Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies.

Gibbs P, Heinemann V, Sharma NK, Taieb J, Ricke J, Peeters M, Findlay M, Robinson B, Jackson C, Strickland A, Gebski V, Van Buskirk M, Zhao H, van Hazel G; SIRFLOX and FOXFIRE Global Trial Investigators.

Clin Colorectal Cancer. 2018 Dec;17(4):e617-e629. doi: 10.1016/j.clcc.2018.06.001. Epub 2018 Jun 12.

PMID:
30033117

Supplemental Content

Loading ...
Support Center